4.7 Article

Mechanisms of Phenotypic Rifampicin Tolerance in Mycobacterium tuberculosis Beijing Genotype Strain B0/W148 Revealed by Proteomics

Journal

JOURNAL OF PROTEOME RESEARCH
Volume 15, Issue 4, Pages 1194-1204

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jproteome.5b01073

Keywords

rifampicin; Mycobacterium tuberculosis; dormancy; quantitative proteomics; phosphoproteomics

Funding

  1. National Institute for Public Health
  2. Environment (RIVM), SOR Project [S/000134]

Ask authors/readers for more resources

The successful Russian clone B0/W148 of Mycobacterium tuberculosis Beijing is well-known for its capacity to develop antibiotic resistance. During treatment, resistant mutants can occur that have inheritable resistance to specific antibiotics. Next to mutations, M. tuberculosis has several mechanisms that increase their tolerance to a variety of antibiotics. Insights in the phenotypic mechanisms that contribute to drug tolerance will increase our understanding of how antibiotic resistance develops in M. tuberculosis. In this study, we examined the (phospho)proteome dynamics in M. tuberculosis Beijing strain B0/W148 when exposed to a high dose of rifampicin; one of the most potent first-line antibiotics. A total of 2,534 proteins and 191 phosphorylation sites were identified, and revealed the differential regulation of DosR regulon proteins, which are necessary for the development of a dormant phenotype that is less susceptible to antibiotics. By examining independent phenotypic markers of dormancy, we show that persisters of in vitro rifampicin exposure entered a metabolically hypoactive state, which yields rifampicin and other antibiotics largely ineffective. These new insights in the role of protein regulation and post-translational modifications during the initial phase of rifampicin treatment reveal a shortcoming in the antituberculosis regimen that is administered to 8-9 million individuals annually.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation

Dylan P. Noone, Douwe J. Dijkstra, Teun T. van der Klugt, Peter A. van Veelen, Arnoud H. de Ru, Paul J. Hensbergen, Leendert A. Trouw, Thomas H. Sharp

Summary: This study presents a high-resolution structure of the prototypical long pentraxin, PTX3, and reveals a radically different quaternary structure compared to other pentraxins. The structure was obtained using cryo-electron microscopy (cryo-EM) and AlphaFold prediction. The resulting structure provides insights into ligand binding sites and can potentially inform the development of therapies for conditions such as COVID-19, cancer, and female infertility.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Oncology

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

Rosa A. van Amerongen, Renate S. Hagedoorn, Dennis F. G. Remst, Danique C. Assendelft, Dirk M. van der Steen, Anne K. Wouters, Marian van de Meent, Michel G. D. Kester, Arnoud H. de Ru, Marieke Griffioen, Peter A. van Veelen, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Summary: In this study, high-avidity WT1-specific T cells were identified from the allogeneic T-cell repertoire of healthy donors. These T cells showed potent and specific anti-WT1 activity against newly identified WT1 peptides derived from primary leukemia and ovarian carcinoma samples. Additionally, T-cell clones with T-cell receptor (TCR) gene transfer showed antitumor reactivity against WT1-expressing solid tumor cell lines, acute myeloid leukemia (AML) blasts, and ovarian carcinoma patient samples. These findings suggest that these TCRs and naturally expressed WT1 peptides have potential for TCR gene transfer strategies in patients with WT1-expressing tumors, including AML and ovarian carcinoma.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Immunology

Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models

Paula Ruibal, Kees L. M. C. Franken, Krista E. vzn Meijgaarden, Marjolein van Wolfswinkel, Ian Derksen, Ferenc A. Scheeren, George M. C. Janssen, Peter A. van Veelen, Charlotte Sarfas, Andrew D. White, Sally A. Sharpe, Fabrizio Palmieri, Linda Petrone, Delia Goletti, Thomas Abeel, Tom H. M. Ottenhoff, Simone A. Joosten

Summary: Tuberculosis remains a deadly infectious disease worldwide, causing significant social and economic burden. This study developed an improved algorithm to identify Mycobacterium tuberculosis-derived peptides that can activate specific HLA-E-restricted T cells.

JOURNAL OF IMMUNOLOGY (2022)

Article Orthopedics

WWP2 confers risk to osteoarthritis by affecting cartilage matrix deposition via hypoxia associated genes

M. Tuerlings, G. M. C. Janssen, I. Boone, M. van Hoolwerff, A. Rodriguez Ruiz, E. Houtman, H. E. D. Suchiman, R. J. P. van der Wal, R. G. H. H. Nelissen, R. Coutinho de Almeida, P. A. van Veelen, Y. F. M. Ramos, I. Meulenbelt

Summary: The study aims to explore the co-expression network of the osteoarthritis (OA) risk gene WWP2 in articular cartilage and examine the cartilage characteristics when mimicking the effect of OA risk allele rs1052429-A on WWP2 expression in a human 3D in vitro model of cartilage. The study found 98 highly correlated genes in lesioned OA cartilage when performing Spearman correlations. Upregulation of WWP2 in 3D chondrocyte pellet cultures resulted in changes in the expression of various genes and proteins related to cartilage matrix deposition. Additionally, miR-140 was found to be involved in similar pathways as WWP2.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Immunology

Retina-arrestin specific CD8+T cells are not implicated in HLA-A29-positive birdshot chorioretinitis

W. J. Venema, S. Hiddingh, G. M. C. Janssen, J. Ossewaarde-van Norel, N. Dam van Loon, J. H. de Boer, P. A. van Veelen, J. J. W. Kuiper

Summary: This study identified the naturally presented antigenic SAG peptides through HLA-A29 immunopeptidomics and found that SAG is not a CD8+ T cell autoantigen, suggesting that it is not involved in the pathogenesis of BCR.

CLINICAL IMMUNOLOGY (2023)

Article Biochemical Research Methods

O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation

K. Madunic, Y. M. C. A. Luijkx, O. A. Mayboroda, G. M. C. Janssen, P. A. van Veelen, K. Strijbis, T. Wennekes, G. S. M. Lageveen-Kammeijer, M. Wuhrer

Summary: This study identified specific mucin O-glycans that mark butyrate-induced epithelial differentiation of the intestinal cell line CaCo-2 using porous graphitized carbon nano-liquid chromatography with electrospray ionization tandem mass spectrometry. The results showed that the fully differentiated butyrate-stimulated cells have a higher expression of sialylated O-glycan structures, while fucosylation is downregulated during differentiation. These findings provide insights into the dynamic O-glycosylation patterns in the gut and their functional role in gut-microbiota homeostasis and dysbiosis.

MOLECULAR & CELLULAR PROTEOMICS (2023)

Article Oncology

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain

Miranda H. Meeuwsen, Anne K. Wouters, Tassilo L. A. Wachsmann, Renate S. Hagedoorn, Michel G. D. Kester, Dennis F. G. Remst, Dirk M. van der Steen, Arnoud H. de Ru, Els P. van Hees, Martijn Kremer, Marieke Griffioen, Peter A. van Veelen, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Summary: Jchain is highly expressed in multiple myeloma (MM) and Jchain-derived peptides presented in HLA molecules may be suitable antigens for T-cell therapy of MM. Using immunopeptidomics, Jchain-derived epitopes presented by MM cells were identified, and Jchain-specific T-cell clones were isolated using pHLA tetramer technology. TCRs targeting Jchain-derived peptides presented in four common HLA alleles demonstrated potent preclinical anti-myeloma activity, encouraging further preclinical testing and ultimately clinical development.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Article Multidisciplinary Sciences

N-terminal acetylation can stabilize proteins independent of their ubiquitination

Bert van de Kooij, Evert de Vries, Rogier W. Rooswinkel, George M. C. Janssen, Frederique K. Kok, Peter A. van Veelen, Jannie Borst

Summary: The majority of proteins in mammalian cells are modified by N-terminal acetylation, which can have both inhibitory and promoting effects on protein degradation. However, proteome-wide stability measurements did not find a consistent correlation between N-terminal acetylation and protein stability. By analyzing protein stability datasets, it was found that N-terminal acetylation positively correlates with protein stability for GFP, but this correlation does not apply to the entire proteome. Further experiments showed that N-terminal acetylation can affect protein stability through competition with N-terminal ubiquitination, as well as other mechanisms independent of ubiquitination status.

SCIENTIFIC REPORTS (2023)

Article Microbiology

The alphavirus nonstructural protein 2 NTPase induces a host translational shut-off through phosphorylation of eEF2 via cAMP-PKA-eEF2K signaling

Emmely E. E. Treffers, Ali Tas, Florine E. M. Scholte, Arnoud H. H. de Ru, Eric J. J. Snijder, Peter A. A. van Veelen, Martijn J. J. van Hemert

Summary: Chikungunya virus (CHIKV) is a reemerging alphavirus that has caused outbreaks in Africa, Asia, and the Americas. Infection with CHIKV induces phosphorylation of eukaryotic elongation factor 2 (eEF2), leading to a shut-off of host-cell translation. This shut-off is mediated by the enzymatic activity of the nsP2 NTPase domain, which increases cellular cAMP concentration and activates PKA and eEF2 kinases. These findings provide insights into how alphaviruses modulate host cell metabolism and shut-off cellular protein synthesis.

PLOS PATHOGENS (2023)

Article Immunology

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer

Rosa A. van Amerongen, Sander Tuit, Anne K. Wouters, Marian van de Meent, Sterre L. Siekman, Miranda H. Meeuwsen, Tassilo L. A. Wachsmann, Dennis F. G. Remst, Renate S. Hagedoorn, Dirk M. van der Steen, Arnoud H. de Ru, Els M. E. Verdegaal, Peter A. van Veelen, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Summary: Recurrent disease is common in ovarian cancer patients. Adoptive T-cell therapies using T-cell receptors (TCRs) targeting tumor-associated antigens (TAAs) show promise in treating less-immunogenic 'cold' ovarian tumors. This study identified PRAME, CTCFL, and CLDN6 as strictly tumor-specific TAAs with high expression in ovarian cancer and low expression in healthy tissues. High-avidity T-cell clones recognizing peptides derived from these TAAs were isolated and showed potent antitumor reactivity in vitro and in vivo. These findings provide valuable candidates for the treatment of ovarian cancer and other PRAME or CTCFL expressing cancers.

FRONTIERS IN IMMUNOLOGY (2023)

Article Oncology

A library of cancer testis specific T cell receptors for T cell receptor gene therapy

Marije A. J. de Rooij, Dennis F. G. Remst, Dirk M. van der Steen, Anne K. Wouters, Renate S. Hagedoorn, Michel G. D. Kester, Miranda H. Meeuwsen, Tassilo L. A. Wachsmann, Arnoud H. de Ru, Peter A. van Veelen, Els M. E. Verdegaal, J. H. Frederik Falkenburg, Mirjam H. M. Heemskerk

Summary: In this study, high-affinity cancer-specific TCRs targeting different melanoma-associated antigens (MAGEs) were identified and tested for antitumor efficacy. The most potent TCRs were transferred into CD8+ T cells and showed efficient reactivity against various tumor types. Seven MAGE-specific TCRs were identified, expanding the pool of cancer patients eligible for TCR gene therapy.

MOLECULAR THERAPY-ONCOLYTICS (2023)

Article Chemistry, Analytical

In-Depth Specificity Profiling of Endopeptidases Using Dedicated Mix-and-Split Synthetic Peptide Libraries and Mass Spectrometry

Bart Claushuis, Robert A. Cordfunke, Arnoud H. de Ru, Annemarie Otte, Hans C. van Leeuwen, Oleg I. Klychnikov, Peter A. van Veelen, Jeroen Corver, Jan W. Drijfhout, Paul J. Hensbergen

Summary: Proteases are enzymes that hydrolyze peptide bonds and play a crucial role in various biological processes. We developed a method to study the cleavage specificity of a group of bacterial metalloproteases and discovered new peptide substrates. Additionally, we characterized a new metalloprotease with a distinct cleavage specificity from the other two studied proteases.

ANALYTICAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains

Leoni Abendstein, Douwe J. Dijkstra, Rayman T. N. Tjokrodirijo, Peter A. van Veelen, Leendert A. Trouw, Paul J. Hensbergen, Thomas H. Sharp

Summary: The authors used cryoEM and MS techniques to investigate IgG3-mediated complement activation and provide the first structural insights into IgG3. IgG3 is distinct from other IgG subclasses due to its extended hinge, allotypic diversity, and enhanced effector functions. However, the lack of structural information has limited its use as an immunotherapeutic candidate.

NATURE COMMUNICATIONS (2023)

Correction Cell Biology

Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT Motifs (vol 33, 108475, 2020)

Birol Cabukusta, Ilana Berlin, Daphne M. van Elsland, Iris Forkink, Menno Spits, Anja W. M. de Jong, Jimmy J. L. L. Akkermans, Ruud H. M. Wijdeven, George M. C. Janssen, Peter A. van Veelen, Jacques Neefjes

CELL REPORTS (2023)

Article Multidisciplinary Sciences

SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome

Daniel Salas-Lloret, Nicolette S. Jansen, Easa Nagamalleswari, Coen van der Meulen, Ekaterina Gracheva, Arnoud H. de Ru, H. Anne Marie Otte, Peter A. van Veelen, Andrea Pichler, Joachim Goedhart, Alfred C. O. Vertegaal, Roman Gonzalez-Prieto

Summary: Ubiquitin and ubiquitin-like conjugation cascades involve E1, E2, and E3 enzymes, with E3s providing substrate specificity. Through mass spectrometry-based approaches, more than 6500 SUMO2/3 target proteins have been identified. Using SUMO-activated target traps (SATTs), the substrates for eight different SUMO E3s were systematically identified, revealing E3 substrate preference. Quantitative proteomics and the Polar SATTs web-based tool were developed to measure substrate specificity and browse the dataset interactively. Overall, the study uncovers the E3-to-target wiring of 1388 SUMO substrates for different SUMO E3 ligases.

SCIENCE ADVANCES (2023)

No Data Available